Across the world, women live longer than men. The reason behind the difference between male and female life expectancy is unclear, but it seems related partially to biological advantages and partially to environmental and behavioral factors. Even though women outlive men, they are more prone to suffering from ill health and other age-related diseases. Women's healthcare, however, especially in less-developed settings, remains mostly confined to reproductive issues, particularly maternal health. Attention to other significant women’s health issues such as cardiology, reproductive health, and urology is growing rapidly.
Overall, the advancements in women’s health diagnostic products are intense, and diagnostic technologies have been subjected to rapid change. Two of the key market drivers are the rising occurrence of lifestyle disorders among women and growing awareness of women-specific health issues. The other drivers include the rise in the number of private diagnostic labs mostly in the emerging nations, health initiatives/drives taken by governments and other health organizations, and new approvals for easy-to-use rapid tests. Nevertheless, the lack of skillful lab professionals and high set-up costs of diagnostic devices/systems are some key restraints to growth in the women’s health diagnostics market.
Currently, women’s health diagnostic products are being targeted at markets outside of the traditional hospital or clinical laboratory. In fact, the demand for home healthcare services in women’s health is facing a steady increase, but, at the same time, there is pressure to lower costs and maintain the high quality of the care delivered at home. Continuous improvements in technology are bringing about a number of new diagnostic tests that consolidate high levels of accuracy with rapid, easy-to-use product designs.
Urological disorders are increasing across the world in line with the growing geriatric population, conditions including nephrolithiasis, commonly known as kidney stones, urinary tract infections (UTIs), stress incontinence, and menorrhagia, all of which play a major role in driving the urology diagnostics market growth. Women are at a greater risk of developing UTIs than men; UTIs are painful and can be potentially dangerous if they spread to the kidneys. Therefore, preventing or quickly treating a UTI is of utmost importance.
This strategic research service provides the key growth drivers and current competitive landscape in the women's urology diagnostics market. Also, it covers the market size and growth rate forecast for 2016 and 2021.
The women's urology diagnostics market has been categorized into POC/molecular tests, lab instrumentation, and surgical instrumentation.
Key Questions This Study Will Answer:
What are the key market opportunities that make this an attractive market with significant future revenue potential for companies?
What is the growth potential for women’s urology diagnostics solutions and its sub-segments across different geographies?
What are the key growth drivers that companies should focus on to remain relevant and competitive in this market?
Who are the top game-changing companies in the women’s urology diagnostics and what are their leading product portfolios?